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Moringa oleifera is a tree native to a number of Asian, African, and Central American countries and has been used in traditional 
medicine for an assortment of medicinal uses for centuries. Due to bioactive compounds within Moringa leaves, it is believed that 
Moringa leaf extract may possess cancer-selective antiproliferative properties. Previous research has been conducted in regards to this 
topic, but poor experimental design due to lack of necessary controls limits the legitimacy of anticancer claims. While previous research 
has shown that Moringa leaf extract has the potential to kill cancer cells, the research fails to demonstrate the effects of Moringa leaf 
extract on healthy cells. In order for anticancer claims to be sufficient and yield the possibility of a future cancer treatment, Moringa 
leaf extract must not harm non-cancerous cells. This is essential in order to be considered a cancer-selective killing agent. The current 
study was designed using tissue type pairs including both cancerous and non-cancerous cell lines. These cell lines were treated with 
increasing concentrations of Moringa leaf extracts. After 48 hours, cell proliferation was measured with CellTiter 96 Aqueous Non-
Radioactive Cell Proliferation Assay, and statistical analyses were completed. Results showed that the Moringa leaf extract had no 
statistically significant effect on either of the breast cell lines, cancerous or non-cancerous. However, the results suggest there is a 
statistically significant difference in cell proliferation between the lung cell lines. Low concentrations increased cell proliferation in the 
healthy lung cells while having no significant effect on the cancerous lung cells. The effects reversed at higher concentrations. This 
could be due to the difference in cell responses between cancerous lung cells and healthy lung cells. Microscopy findings provided 
qualitative results that helped determine the method of cell death occurring by cells treated with Moringa leaf extract. Ideally, an 
effective cancer treatment would cause cancerous cells to die by apoptosis, rather than necrosis. However, the findings suggest necrosis 
is the primary mode of death occurring in the cancerous lung cells, while the cancerous breast cells showed no signs of cell death. This 
research contradicts previous findings that Moringa leaf extract is a cancer killing agent; therefore, more research should be completed 
to understand these new findings. 
Introduction 
 
Moringa oleifera is a hardy tree with small, oval-shaped leaves and a 
thin trunk. It grows in dry places and hanging from its branches are large 
pods containing young seeds. Moringa is a tree of many names and uses, 
for its names range from the horseradish tree and drumstick tree in India, 
to the benzolive tree in Haiti; however, the name “Miracle Tree” has 
commonly been used1. Moringa has been used in traditional medicine for 
centuries, dating back to being used by the ancient Romans and Greeks. 
Ayurvedic medicine, one of the world’s oldest holistic healing systems, 
claims that Moringa can prevent up to 300 diseases, and aside from 
preventative measures, its leaves are capable of curative properties as 
well2. The traditional uses of Moringa are great in number, for they 
include the treatment of bacterial, fungal, viral, and parasitic issues, 
along with asthma, circulatory, digestive, and inflammatory disorders3. 
Other targeted ailments include malaria, typhoid fever, arthritis, 
hypertension, and diabetes. Because of Moringa’s ability to improve the 
immune system, treatment of HIV and AIDS symptoms is also possible2. 
All parts of Moringa have been utilized, for even the seeds are capable 
of purifying water3. With this vast list of traditional medicinal properties, 
it comes as no surprise that Moringa is packed with chemical 
components to give it an astounding phytochemistry. The familiar 
components that give Moringa its nutritional value are its high amounts 
of protein, calcium, iron, fiber, vitamin A, and vitamin B. Due to these 
components, Moringa is currently being advertised as a “super food,” 
possessing higher nutritional value than other nutritious greens such as 
kale. A more in depth look at Moringa’s bioactive compounds in the 
leaves reveals what is responsible for its medicinal properties. Moringa 
contains glucosinolates and isothiocyanates, both of which have shown 
great potential in cancer prevention, for glucosinolates are the naturally 
occurring precursor of isothiocyanates. While the exact mode of action is 
unknown, research has shown that isothiocyanates are a cancer-killing 
agent4,5. 
 A number of Moringa cancer studies have been published by 
researchers with experimental results that conclude by saying Moringa 
has anticancer activity6,7,8,2. But after deeper review of the conducted 
studies, it is apparent that no negative controls were used7,8. While it has 
been shown that Moringa leaf extract has anticancer activity, there is no 
evidence that the same leaf extract would not also kill healthy cells. The 
research is merely showing that at a specified concentration of Moringa 
leaf extract, cancer cells will not survive as well as if they were not  
 
treated with the extract. This is an insignificant claim; if healthy cells are 
killed or damaged at the same rate, Moringa leaf extract has no potential 
of possibly being developed into a cancer drug. Also, controls must be 
conducted regarding the extract solvent used. The solvent without leaf 
extract must be applied to the cells to affirm that the solvent is not 
producing the anticancer effect. Another aspect to consider to determine 
the possibility of Moringa as a cancer treatment is the type of cell death 
that results, whether it be apoptosis or necrosis. Apoptotic cells undergo 
shrinking, nuclear condensation, and disconnect from neighboring cells 
or extracellular matrix. By achieving this sort of cell death, the outside 
environment is left unaffected. Necrosis, however, is considered to be an 
“accidental” cell death that is uncontrollable and lacks order. When 
cancer cells undergo necrosis, the cell membrane is disrupted in a way 
that results in the intracellular components being released into the 
surrounding cellular environment. This release of material will lead to an 
inflammatory response by immune cells, which could possibly lead to 
further tumor growth9. In light of this information, it is important to test 
the programmed cell death being achieved by the cancer cells in 
experimentation. More research is needed in determining whether or not 
Moringa leaf extract is cancer-selective in its antiproliferative properties 





Moringa oleifera seeds were generously provided by Dr. Jed Fahey from 
Johns Hopkins University. The seeds were cultivated according to the 
standards recommended by his lab. The seeds were planted in a soil 
mixture containing a 2:1 ratio of potting soil to sand. The plants grew in 
an environmental chamber with 15 hours of light per day at 29oC. The 
plants were lightly sprayed with water once a day. Two weeks after 
planting, the sprouts were transferred to a larger container for optimal 
room for growth. Two months after planting, all viable, healthy leaves 
were stripped from the plants and placed in a specimen bag to dry in a 
vented chamber for one week. After drying, the leaves were ground with 
a mortar and pestle until reaching the consistency of a fine powder. A 
second source of Moringa oleifera leaf powder was obtained from Kuli 
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Extraction  
Moringa leaf powder (MOL) in the amount of 3.74 g was extracted by a 
Soxhlet apparatus with 95% ethanol. The extraction ran for 8 hours until 
all soluble constituents had dissolved in the solvent. A rotary evaporator 
was then used to evaporate the solvent at 60oC. Moringa leaf extract was 
collected at an amount of 0.4 g. The extraction procedure was repeated 
with the Kuli Kuli Moringa leaf powder (MOP). From the solid extract 
collected, a 5 mg/mL stock solution was made for each Moringa extract 
with a 95% ethanol solvent.  
 
Cell culture: A549/NL20 and MDA-MB-231/MCF-10A 
The human lung cell carcinoma cell line A549 (ATCC no. CRM-CCL-
185) was cultured in DMEM, containing 10% fetal bovine serum (FBS) 
and 100 μg/mL gentamicin. The human lung cell line NL20 (ATCC no. 
CRL-2503) was cultured in Hams F12 media which includes 1.2 g/L 
sodium bicarbonate, 1.8 g/L glucose, and 1mM L-glutamine. Other 
added chemicals include 1.5g/L sodium bicarbonate, 2.7 g/L glucose, 
200 mM L-glutamine, 10mM nonessential amino acids, 100mg/mL 
insulin, 10mg/mL transferrin, 100% FBS, 0.1 μg/μL epidermal growth 
factor, 5 μg/μL hydrocortisone, and 100μg/mL gentamicin. The human 
breast cell carcinoma cell line MDA-MB-231 (ATCC no. CRM-HTB-
26) was cultured in RPMI, containing 10% FBS. The human breast cell 
line MCF-10A (ATCC no. CRL-10317) was cultured in DMEM, 
containing 5% horse serum, 20 ng/mL EGH, 0.5 mg/mL hydrocortisone, 
100 ng/ml cholera toxin, 10 μg/mL insulin, and 5.0 mL pen/strep. All 
cell lines were grown at 37oC with 5% CO2.  
 
Dilution of extracts 
The 5 mg/mL stock solution of MOL extract was diluted to achieve final 
concentrations of 300 μg/mL, 200 μg/mL, 100 μg/mL, and 50 μg/mL 
with A549, NL20, MDA-MB-231, and MCF-10A media. The 5 mg/mL 
stock solution from the MOP extract was also diluted with each cell 
media to the same concentrations. To serve as a negative control, similar 
dilutions with the cell types’ respective medias were made using 95% 
ethanol solvent in place of Moringa extracts.  
 
Proliferation assay 
Four 96 well plates were used to plate 39 wells of each cell type per 
plate at 5000 cells/200 μL media. The plates were then placed in 
incubation overnight at 37oC. After incubation, the cells were treated in 
triplicates with each of the MOL and MOP extract concentrations and 
ethanol controls. The plates were left to incubate for 48 hours at 37oC. 
 After 48 hours of incubation, the 96 well plates were spun at 600g 
for one minute. Media was removed, and 100 μL of fresh media was 
added to each well to remove any spectrophometric differences due to 
the extract additions. The CellTiter 96 Aqueous Non-Radioactive Cell 
Proliferation Assay was used according to its protocol, and the plates 
were incubated for 3.5 hours. The 96 well plates were then read on a 




Cells were passed and resuspended in media at a concentration of 10,000 
cells/133 μL media. Cells were plated in an 8 well chamber slide and 
incubated for 24 hours at 37oC. Cells were then treated with 67 μL of 50 
μg/mL and 300 μg/mL MOL extract concentrations and ethanol controls 
and left to incubate for another 24 hours at 37oC. MOL extract-treated 
wells and control wells were stained with Biotium’s Apoptosis, 
Necrosis, and Healthy Cell Quantification Kit following the protocol 
given in the product information. Cell plates were then imaged with a 
Nikon TiEclipse Inverted Microscope. 
 
Statistical calculation 
Fold changes from the average control value were calculated from the 
raw data and used in all statistical calculations, where fold change was 
the absorbance of treatment divided by the average absorbance of the 
ethanol control. Fold change values accounted for the effects of the 
ethanol in the MOL and MOP extracts on cell proliferation, so that the 
effect of Moringa on cell proliferation could be observed, rather than the 
effect of Moringa and ethanol in combination. Fold change values also 
allowed for the direct comparison of cell lines that responded differently 
in degree of color change to the application of the CellTiter 96 Aqueous 
Non-Radioactive Cell Proliferation Assay. A Levene’s test was 
calculated using JASP, version 0.7.5.5. Two-way ANOVAs with 
Bonferroni posttests were calculated using GraphPad Prism. Differences 




The effects of Moringa oleifera leaf extract were tested on MDA-MB-
231, MCF-10A, A549, and NL20 cell proliferation. An initial Levene’s 
test showed there was unequal variance in the conditions. Because this 
violated an assumption of ANOVA, the ANOVA was run with the 
understanding that there was the potential for inflated type I errors.  
 
Effects of MOL and MOP extracts on breast cell proliferation 
The raw absorbance values of the MDA-MB-231 and MCF-10A cell 
lines treated with MOL and MOP extracts showed no identifiable trends 
in cell proliferation (Figure 1). 
 An ANOVA was completed on fold change values for treatment of 
MOL and MOP extracts on MDA-MB-231 and MCF-10A, showing no 
statistical significance at any of the extract concentrations (p > 0.05). 
There were also no identifiable trends in cell proliferation that could be 
observed in either breast cell line (Figure 2).  
 
Effects of MOL and MOP extracts on lung cell proliferation 
The raw absorbance values of the A549 and NL20 cell lines treated with 
MOL and MOP extracts showed that increasing amounts of ethanol had 
a negative effect on cell proliferation in A549 cells, but when in 
combination with Moringa, cell number increases (Figure 3). It was also 
evident that the NL20 cell line responded differently to the CellTiter 96 
Aqueous Non-Radioactive Cell Proliferation Assay than the A549 cell 
line, by producing much lower absorbance values (Figure 3). The 
absorbance differences between cell lines can be accounted for by 
calculating fold change values. 
 An ANOVA for treatment of MOL and MOP extracts on fold 
change values of A549 cells revealed no statistical significance at any of 
the extract concentrations (p > 0.05). Although the A549 data lacked 
statistical significance, there was an upward trend in cell proliferation 
with increasing concentration of MOL and MOP extract. At 50 and 100 
μg/mL of MOL and MOP extracts, the fold change of A549 cell 
proliferation did not differ from the control. However, at 200 and 300 
μg/mL of MOL and MOP extracts, the fold change of A549 cell 
proliferation doubled that of the control (Figure 4).  
 An ANOVA for treatment on NL20 cells revealed significance at 50 
μg/mL of MOL extract (p ≤ 0.001), 50 μg/mL of MOP extract (p ≤ 
0.05), and 100 μg/mL of MOP extract (p ≤ 0.001) with a fold change 
reaching heights of nine times the control. The two highest 
concentrations of MOL extract and MOP extract on NL20 cells showed 
no statistical significance with cell proliferation measuring below the 
control (Figure 4). 
 
Evaluation of cell death 
Cell staining and microscopic imaging allowed for cell death to be 
evaluated in each of the cell lines at the lowest and highest 
concentrations of MOL extract. Although these results are not 
quantitative, the information can help paint a larger picture of what may 
be happening to the cells after the addition of the MOL extracts. The 
MCF-10A cells appeared to die primarily by apoptosis at 50 μg/mL of 
MOL extract, while dying primarily by necrosis at 300 μg/mL of MOL 
extract (Figure 5). These findings suggest that although an overall 
change in cell number is not observed due to increasing concentrations 
of MOL extract (Figure 2), the method of cell death may be changing as 
the concentration of MOL extract increases. The MDA-MB-231 cells 
appeared healthy with limited cell death occurring at both concentrations 
of MOL extract (Figure 5).  
 At 50 μg/mL of MOL extract, the NL20 cells revealed a much 
smaller percentage of cell death occurrence than the NL20 cells treated 
with 300 μg/mL of MOL extract (Figure 6). These findings match the 
proliferation data that showed that NL20 cells had greater proliferation 
at low concentrations of MOL extract and less proliferation at high 
concentrations of MOL extract (Figure 4). The cell death experienced by 
NL20 cells at 300 μg/mL of MOL extract also appeared to be occurring  
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by apoptosis, not necrosis (Figure 6). The A549 cells appeared to show 
increasing amounts of necrosis with increasing concentrations of MOL 




A violation of the Levene’s test presents a possible limitation of this 
study’s findings, suggesting that the significance found by the ANOVAs 
could be a result of false positive results. However, data trends are 
evident, suggesting that the cell proliferation data collected in this study 
indicates that low concentrations of Moringa leaf extract increase 
healthy cell proliferation, especially evident in healthy lung cells (Figure 
4). The images gathered by microscopic imaging showed that death in 
healthy cells at low MOL extract concentrations occurs by apoptosis or 
not all (Figures 5 and 6). In regards to method of cell death, apoptosis is 
preferred to necrosis because it prevents the outward environment of the 
dying cell from being affected. High concentrations of Moringa leaf 
extract decreased cell proliferation in healthy lung cells (Figure 4), 
suggesting that there may be a window of optimal concentration of 
Moringa leaf extract on healthy cells. In cancer cell lines, low levels of 
Moringa leaf extract did not have a significant effect on cancerous breast 
cells or cancerous lung cells (Figures 2 and 4). In fact, cancerous lung 
cells showed a steady increase in cell proliferation with increasing 
concentrations of MOL and MOP extracts (Figure 4), refuting the 
likelihood that Moringa could serve as a cancer-killing agent. 
Microscopic imaging of cancerous cells also did not show promising 
results for the use of Moringa as a cancer treatment option, for cell death 
did not appear to be occurring at all in the cancerous breast cells (Figure 
5). These findings contradict a similar study that treated the same 
cancerous breast cell line, MDA-MB-231, with Moringa leaf extract and 
found “significantly low” cell survival above 250 μg/mL due to the 
induction of apoptosis7. Cell death in A549 cells suggests that necrosis is 
the primary mode of death with increasing concentration of MOL extract 
(Figure 6). This finding would also discredit the use of Moringa as a 
cancer-killing agent because cancer cell death achieved by necrosis 
would yield an inflammatory response and possible further tumor 
growth. When comparing the difference between MOL and MOP 
extracts on cell proliferation, no statistically significant differences were 
found (Figures 2 and 4).  
 Research previously reported has made contradictory conclusions to 
the ones made in this study. Although Al-Asmari et al.’s research using 
cancerous breast cells could not be reproduced, similar results were 
observed in the cancerous lung cells. However, different conclusions can 
be drawn because of the inclusion of ethanol controls. Corrected 
absorbance values of A549 cells showed that cell number decreased with 
increasing amounts of MOL and MOP extracts (Figure 3), which could 
suggest the conclusion that Moringa is resulting in decreased cancer cell 
proliferation. The inclusion of an ethanol control, however, showed that 
ethanol was also having an effect on cell proliferation. As ethanol 
percentage increased, cell number decreased (Figure 3). With the 
addition of Moringa, cell number increased above that of the control, a 
conclusion that could only be made with the use of fold change values. 
Al-Asmari et al. failed to account for the effects of ethanol in the 
Moringa extracts used, which led to the conclusion that Moringa was 
Figure 1. Raw absorbance values of MDA-MB-231 and MCF-10A 
with increasing MOL and MOP extract concentrations compared to 
ethanol controls.  
 
Figure 2. Fold change of MDA-MB-231 and MCF-10A with increasing 
MOL and MOP concentrations. * p<0.05, ** p<0.01, *** p<0.001 
 
 
Figure 3. Raw absorbance values of A549 and NL20 with increasing 
MOL and MOP extract concentrations compared to ethanol controls.  
Figure 4. Fold change of A549 and NL20 with increasing 
MOL and MOP extract concentrations. * p<0.05, ** p<0.01, 
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Figure 5. Effects of MOL extract addition to breast cell lines, MCF-10A and MDA-MB-231. DAPI - cell 
nucleus, FITC - apoptotic cells, and TRITC - necrotic cells. 
 
Journal of the South Carolina Academy of Science, [2017], 15(2)  | 12 
Undergraduate Research Article 
Figure 6. Effects of MOL extract addition to lung cell lines, NL20 and A549. DAPI - cell nucleus, FITC - 
apoptotic cells, and TRITC - necrotic cells. 
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killing cancer cells, when in reality, Moringa was slightly rescuing the 
cells from the harmful effects of ethanol. Future research should be 
conducted to determine why ethanol had such harmful effects on 
cancerous lung cells while breast cells were unharmed. The difference in 
proliferation response to ethanol between the lung and breast cell lines 
suggests a significant difference between the two cell lines. 
 Past research has also shown that Moringa leaf extract results in a 
reduction of cancer cell growth, while not comparing the treatment of 
Moringa leaf extract on normal cells7,8. One study found that Moringa 
leaf extract “showed greater cytotoxicity for tumor cells than for normal 
cells”6, but this finding was also contradicted (Figures 2 and 4). One 
explanation lies in a dilemma that has been faced by the scientific 
community in recent years, a reproducibility crisis. An alarmingly high 
percentage of high-impact preclinical cancer papers have been unable to 
be replicated, and questions have begun to arise as to whether research 
experiments do not possess adequate controls or if the integrity of 
researchers should be in question. Although the purpose of this study is 
not to question the motives of other scientists, the contradictory results 
found may merit future attempts at reproducibility in research. 
 The results of this study do not support the use of Moringa leaf 
extract as a cancer-killing agent or future cancer treatment option; 
however, this does not discredit the use of Moringa for other medicinal 
uses. The increase in cell proliferation of normal lung cells at low 
concentrations of Moringa leaf extracts reinforces the healing properties 
that have been associated with Moringa for centuries, revealing that 
Moringa is beneficial to normal cells at appropriate concentrations. 
Although Moringa is unlikely to be a cancer-killing agent, it could still 
be an effective cancer preventative by increasing normal cell 
proliferation and preventing cancer cells from achieving metastatic 
growth. Future research in this area should be conducted to determine 
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